<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04213755</url>
  </required_header>
  <id_info>
    <org_study_id>ROTEM in placenta previa</org_study_id>
    <nct_id>NCT04213755</nct_id>
  </id_info>
  <brief_title>ROTEM in Patients With Placenta Previa</brief_title>
  <official_title>Rotational Thromboelastometry During Cesarean Section as a Predictive Evaluation for Progression of Intraoperative Massive Hemorrhage in Parturients With a Potential Risk of Perioperative Hemorrhage: a Prospective Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Bundang Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The rotational thromboelastogram (ROTEM) test can be performed on patients with placenta
      previa/accreta/increta/percreta who have a high likelihood of massive bleeding, and the
      predictors can be identified by comparing the patients who actually show massive bleeding
      with those who do not.

      Applying these predictive factors to pregnant women undergoing cesarean section after
      diagnosis of placenta previa/accreta/increta/percreta, it will be advantageous for the
      perioperative management because it is possible to select pregnant women with a factor of
      massive bleeding.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Blood loss</measure>
    <time_frame>1 min after finishing an operation</time_frame>
    <description>Volume of intraoperative blood loss</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of INTEM</measure>
    <time_frame>10 min after spinal anesthesia, 5 min after baby delivery, 1 min after finishing operation</time_frame>
    <description>intrinsic pathway component</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of EXTEM</measure>
    <time_frame>10 min after spinal anesthesia, 5 min after baby delivery, 1 min after finishing operation</time_frame>
    <description>extrinsic pathway component</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of APTEM</measure>
    <time_frame>10 min after spinal anesthesia, 5 min after baby delivery, 1 min after finishing operation</time_frame>
    <description>fibrinolytic component</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of FIBTEM</measure>
    <time_frame>10 min after spinal anesthesia, 5 min after baby delivery, 1 min after finishing operation</time_frame>
    <description>the level of fibrinogen</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Placenta Previa</condition>
  <condition>Placenta Accreta</condition>
  <condition>Placenta Increta</condition>
  <condition>Placenta Percreta</condition>
  <arm_group>
    <arm_group_label>patients with risks of intraoperative massive bleeding</arm_group_label>
    <description>patients with risks of intraoperative massive bleeding</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>ROTEM</intervention_name>
    <description>ROTEM including INTEM, EXTEM, APTEM, and FIBTEM</description>
    <arm_group_label>patients with risks of intraoperative massive bleeding</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant women over 20 years old who are scheduled for cesarean section under spinal
        anesthesia after diagnosis of placenta previa/increta/percreta/accreta
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cesarean section under spinal anesthesia

          -  Placenta previa

          -  Placenta accreta

          -  Placenta increta

          -  Placenta percreta

        Exclusion Criteria:

          -  Coagulopathy

          -  Medication with antiplatelets or anticoagulants
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <state>Gyeonggi</state>
        <zip>13620</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hyo-Seok Na</last_name>
      <phone>01087012913</phone>
      <email>hsknana@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>December 24, 2019</study_first_submitted>
  <study_first_submitted_qc>December 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 30, 2019</study_first_posted>
  <last_update_submitted>March 1, 2020</last_update_submitted>
  <last_update_submitted_qc>March 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>Hyo-Seok Na</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Placenta Previa</mesh_term>
    <mesh_term>Placenta Accreta</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

